Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.

Psychiatry research - 30 Apr 2011

Almos Péter Z, Horváth Szatmár, Czibula Agnes, Raskó István, Domján Nóra, Juhász Anna, Janka Zoltán, Kálmán János

Abstract excerpt

There are conflicting results regarding the role of tau (MAPT) haplotypes in neurodegenerative disorders. Recent reports suggest that ethnicity factors and gene-gene interactions may influence the risk of developing Alzheimer's disease (AD). The present study investigates possible synergism between MAPT haplotype and ApoE state in Hungarian Caucasian AD cases (n=91) and control (n=83) population. The difference...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein E4

Share to Factor Analysis, Statistical

Share to Genome-Wide Association Study

Share to Haplotypes

Share to Psychiatric Status Rating Scales

Share to tau Proteins

Source

Identifiers

PMID: 20837363
DOI: 10.1016/j.psychres.2010.08.020

Genes

MAPT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.PMID 20837363Read ↗

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriersSemantic proximity Read ↗

The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment.Semantic proximity Read ↗

MAPT Haplotype Variation and Alzheimer's Disease Risk: A Narrative Review with Focus on the Jordanian Population.Semantic proximity Read ↗

Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.Semantic proximity Read ↗

MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.Semantic proximity Read ↗

The H2 MAPT haplotype is associated with familial frontotemporal dementia.Semantic proximity Read ↗

Association ofMAPThaplotype‐tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohortSemantic proximity Read ↗

Navigating the ALS Genetic Labyrinth: The Role of MAPT Haplotypes.Semantic proximity Read ↗

The synergistic risk effect of apolipoprotein ε4 and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) haplotype for Alzheimer's disease.Semantic proximity Read ↗

The associations between the MAPT polymorphisms and Alzheimer's disease risk: a meta-analysis.Semantic proximity Read ↗

Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western EuropeSemantic proximity Read ↗

Association between H2 haplotype of microtubule associated protein tau gene (deletion / insertion) with Alzheimer Disease in Tunisian patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.